维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Laverman GD"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Effect of a reduction in uric acid on renal outcomes during losartan treatment:a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial显示文摘	Miao Y Ottenbros SA Laverman GD	2011	Hypertension2011，58，1：	1
2	Optimal dosing of renin-angio- tensin-aldosterone system blockers for renal protection : a solved is- sue 显示文摘	Laverman GD Bakker S J Naris GJ	2009	Diabetologia2009，52，6：	1
3	Dual blockade of the renin- angiotensin-aldosterone system in cardiac and renal disease 显示文摘	Slagman MC Naris G Laverman GD	2010	Curr Opin Nephrol Hypertens2010，19，2：	1
4	ACE inhibition versus angiotensin receptor blockade : which is better for renal and cardiovascular protection? 显示文摘	Laverman GD Remuzzi G Ruggenenti P	2004	J Am Soc Nephrol2004，15，1：	1
5	Dual reninangiotensin system blockade at optimal doses for proteinuria 显示文摘	Navis G Henning RH	2002	Kidney Int2002，62，3：	1
6	Effeet of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mcllitus with the Angiotensin II Antagonist Losartan Trial显示文摘	Miao Y Ottenbros SA Laverman GD	2011	Hypertension2011，58，1：	1
7	Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial显示文摘	Miao Y Ottenbros SA Laverman GD	2011	Hypertension2011，58，1：	1
8	Effect of a reduction in uric acid on renal outcomes during losartan treatment:a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial显示文摘	Miao Y Ottenbros SA Laverman GD	2011	Hypertension2011，58，1：	1
9	ACE inhibition ver- sus an-giotensin receptor blockade:which is better for renal and cardiovascularprotection显示文摘	Laverman GD Remuaai G Ruggenenti P	2014	Journal of the American So- ciety of Nephrology2014，16，4：	1
10	Dual reninangiotensin system blockade at optimal doses for proteinuria显示文摘	Laverman GD Navis G Henning RH	2002	Kidney Int2002，62，3：	1
11	Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial显示文摘	MIAO Yan Ottenbros SA Laverman GD et ai	2011	Hypertension2011，58，1：	1
12	ACE inhibition versus angiotensin receptor blockade:which is better for renal and cardiovascular protection显示文摘	Laverman GD Remuzzi G Ruggenenti P	2004	J Am Soc Nephrol2004，15，：	1
13	An initial reduction in serum uric acid during Angiotensin receptor blocker treat- ment is associated with cardiovascular protection: a post-hoc a- naiysis of the RENAAL andI DN Ttrials 显示文摘	Smink PA Bakker S J Laverman GD	2012	J Hypertens2012，30，5：	1
14	ACE inhibition versus angiotensin receptor blockade:which is better for renal and cardiovascular protection显示文摘	Laverman GD Remuaai G Ruggenenti P	2004	J Am Soc Nephrol2004，15，：	1
15	ACE inhibition versus angiotensin receptor blockade:which is better for renal and cardiovascular protection显示文摘	Remuaai G Ruggenenti P	2004	J Am Soc Nephrol2004，15，1：	1
16	ACE inhibition versus angiotensin receptor blockade:which is better for renal and cardiovascular protection显示文摘	Laverman GD Remuaai G Ruggenenti P	2004	J Am Soc Nephrol2004，15，：	1
17	Combined effects of ACEI and ATI blockade in proteinuric patients显示文摘	Laverman GD Navis GJ Henning RH	2002	Kidney Int2002，62，：	1
18	Renoproteetion with and without blood pressure reduction 显示文摘	Laverman GD Andersen S Rossing P	2005	Kidney Int Suppl2005，，94：	1
19	ACE inhibition versus angiotensin receptor blockade:which is better for renal and cardiovascular protection 显示文摘	Laverman GD Remuzzi G Ruggenenti P	2004	J Am Soe Nephrol2004，15，：	1
20	Improvement of sodium status to optimize the efficacy of Renin-Angiotensin system blockade显示文摘	Laverman GD Navis G	2011	Curr Hypertens Rep2011，13，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示